Stephen Stahl: $3,581,159 in payments from Pharma

In my last post I considered the level of transparency provided by the British Association for Psychopharmacology (BAP) in relation to its recently published Guidelines on prescribing for depressive disorders. … Continue reading Stephen Stahl: $3,581,159 in payments from Pharma

British Association for Psychopharmacology Guidelines (BAP)

The above Evidence-based guidelines for treating depressive disorders with antidepressants have recently been published. The British Association for Psychopharmacology are an organisation highly regarded by my profession of psychiatry. 12% of their … Continue reading British Association for Psychopharmacology Guidelines (BAP)

British Medical Journal, 24 January 2015

This week’s BMJ provides a useful overview of the thorny issue of seeking an earlier diagnosis in dementia. I have always argued that a push for “early” diagnosis, using what … Continue reading British Medical Journal, 24 January 2015

“This House supports the early detection of dementia”

This debate was part of  the Northern and Yorkshire Autumn Conference of the Royal College of Psychiatrists and was held in Durham, on Friday 26th September 2014. The motion was … Continue reading “This House supports the early detection of dementia”